Jaegil Kim
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Genomics and Diagnostics, Occupational and environmental lung diseases, Medical Imaging and Pathology Studies
Most-Cited Works
- → Mutational heterogeneity in cancer and the search for new cancer-associated genes(2013)5,657 cited
- → An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics(2018)3,844 cited
- → Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas(2015)3,198 cited
- → Comprehensive molecular characterization of urothelial bladder carcinoma(2014)3,027 cited
- → Integrated Genomic Characterization of Papillary Thyroid Carcinoma(2014)3,018 cited
- → Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma(2017)2,502 cited
- → A Consensus Molecular Classification of Muscle-invasive Bladder Cancer(2019)1,316 cited
- → Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma(2017)903 cited
- → The Immune Landscape of Cancer(2019)794 cited
- → The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma(2018)787 cited